Afya Stock Jumps as Investors Look Past Margins to Brazilian Medical Education's Core Strength
Brazilian medical education giant Afya, a rare US-listed stock, saw its shares rise as investors absorb a recent strong earnings report.
Shares of Afya Limited, the largest medical education group in Brazil, rose 3.21% to close at $13.84 on Monday, as investors warmed to the solid financial foundation revealed in the company's recent earnings report. The Brazilian company, which operates a vast network of medical schools and a digital ecosystem for physicians, reported its second-quarter and first-half 2026 results late last week, showing resilient top-line growth despite margin pressure from a major investment cycle.
Afya is a key player in the country's efforts to address a shortage of physicians, offering an end-to-end ecosystem that guides students from their undergraduate medical degrees through continuing education and into professional practice with clinical management tools. The company’s financial results showed that its core medical schools business is holding up, with first-half revenue growing 7.0% year-over-year to R$1.98 billion and net income climbing 6.8% to R$463.1 million.
The current stock movement suggests investors are beginning to focus on this fundamental strength and the company's strong capital allocation, rather than the initial market concern over a slight dip in margins. Afya is deliberately investing heavily in its higher-growth digital and continuing education segments, which caused its Adjusted EBITDA margin to narrow by 190 basis points to 46.2% for the first half of the year. However, the company’s operating cash conversion remained robust at 87.8%, and management returned R$448 million to shareholders through dividends and share repurchases.
By expanding its footprint in medical training and related technology, Afya is positioning itself to be a long-term beneficiary of Brazil’s demand for qualified doctors and specialized healthcare professionals. Management reaffirmed its revenue guidance for the full year 2026, signaling confidence that the current investments will translate into future growth.
What it touches Afya Limited (AFYA) is one of a small number of Brazilian companies whose shares trade directly on the Nasdaq, allowing American retail investors to buy and sell the stock without requiring an American Depositary Receipt (ADR). The company operates a total of 3,768 medical school seats and a digital platform used by approximately 295,000 users.